| Multiple Sclerosis |
1 |
1 |
| Multiple Sclerosis Relapse |
0 |
0.99 |
| Respiratory Tract Infections |
0 |
0.6 |
| Arthralgia |
0 |
0.32 |
| Urinary Tract Infection |
0 |
0.32 |
| Board Certification |
0 |
0.3 |
| Dizziness |
0 |
0.3 |
| Pain |
0 |
0.3 |
| Cardiovascular Risk Management |
0 |
0.28 |
| Pain Management |
0 |
0.28 |
| Back Pain |
0 |
0.22 |
| Hypertension |
0 |
0.18 |
| A-Scan Biometry |
0 |
0.15 |
| California |
0 |
0.15 |
| Cardiovascular disease |
0 |
0.15 |
| Clinical Research |
0 |
0.15 |
| Disease-Modifying Therapy |
0 |
0.15 |
| Interferon Beta |
0 |
0.15 |
| Scan |
0 |
0.15 |
| Biologic Therapy |
0 |
0.1 |
| Care and Maintenance of Vision |
0 |
0.1 |
| Cataract |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.1 |
| Osteoarthritis |
0 |
0.1 |